From cause to solution of End-stage renal disease: Kidney transplant from a donor with polycystic kidney disease, case report, and review of the literature

ashraf el-hinnawi; Patricia Coutinho; Valberto Sanha; Mokeem Nusair; georgios vrakas

doi:10.58877/japaj.v1i3.88

Authors

ashraf el-hinnawi University of Florida
Patricia Coutinho Universidade Federal de Pernambuco
Valberto Sanha university of Health Science of Porto Alegre
Mokeem Nusair Yarmouk University
georgios vrakas University of Florida

DOI:

https://doi.org/10.58877/japaj.v1i3.88

Keywords:

kidney transplant, polycystic kidney disease

Abstract

Introduction: Kidney transplantation is well established as the treatment of choice for end-stage renal disease (ESRD) patients, offering more remarkable survivability and quality of life. Due to the shortage of organs and rising demand, the use of marginal donors has increased in transplant centers. Herein, we report our experience with two renal transplants from a donor with polycystic kidney disease with normal kidney function.

References

Turin TC, Tonelli M, Manns BJ, Ravani P, Ahmed SB, Hemmelgarn BR. Chronic kidney disease and life expectancy. Nephrol Dial Transplant. 2012;27(8):3182-6. DOI: https://doi.org/10.1093/ndt/gfs052

Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Agodoa LY, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med. 1999;341(23):1725-30. DOI: https://doi.org/10.1056/NEJM199912023412303

Woon C, Bielinski-Bradbury A, O'Reilly K, Robinson P. A systematic review of the predictors of disease progression in patients with autosomal dominant polycystic kidney disease. BMC Nephrol. 2015;16:140. DOI: https://doi.org/10.1186/s12882-015-0114-5

Shamali A, Milsom-Mcquillan S, Gibbs P. Outcomes of renal transplant from donors with polycystic kidney disease. Int J Surg. 2018;51:229-32. DOI: https://doi.org/10.1016/j.ijsu.2018.01.049

Abouna GM. Organ shortage crisis: problems and possible solutions. Transplant Proc. 2008;40(1):34-8. DOI: https://doi.org/10.1016/j.transproceed.2007.11.067

Aung TT, Bhandari SK, Chen Q, Malik FT, Willey CJ, Reynolds K, Jacobsen SJ, Sim JJ. Autosomal Dominant Polycystic Kidney Disease Prevalence among a Racially Diverse United States Population, 2002 through 2018. Kidney360. 2021 Sep 22;2(12):2010-2015. doi: 10.34067/KID.0004522021. PMID: 35419536; PMCID: PMC8986058. DOI: https://doi.org/10.34067/KID.0004522021

Churchill DN, Bear JC, Morgan J, Payne RH, McManamon PJ, Gault MH. Prognosis of adult onset polycystic kidney disease re-evaluated. Kidney Int. 1984;26(2):190-3. DOI: https://doi.org/10.1038/ki.1984.154

Parfrey PS, Bear JC, Morgan J, Cramer BC, McManamon PJ, Gault MH, et al. The diagnosis and prognosis of autosomal dominant polycystic kidney disease. N Engl J Med. 1990;323(16):1085-90. DOI: https://doi.org/10.1056/NEJM199010183231601

Schrier RW, Brosnahan G, Cadnapaphornchai MA, Chonchol M, Friend K, Gitomer B, et al. Predictors of autosomal dominant polycystic kidney disease progression. J Am Soc Nephrol. 2014;25(11):2399-418. DOI: https://doi.org/10.1681/ASN.2013111184

Cachat, Francois; Renella, Raffaele (2016). Risk of cancer in patients with polycystic kidney disease. The Lancet Oncology, 17(11), e474–. doi:10.1016/S1470-2045(16)30529-0 DOI: https://doi.org/10.1016/S1470-2045(16)30529-0

Yu TM, Chuang YW, Yu MC, et al. Risk of cancer in patients with polycystic kidney disease: a propensity-score matched analysis of a nationwide, population-based cohort study. Lancet Oncol 2016; 17: 1419–25 DOI: https://doi.org/10.1016/S1470-2045(16)30250-9

Altheaby A, Almukhlifi A, Aldoukhi A, Alfaleh A, Aboalsamah G, Alshareef A, et al. Why Living Kidney Donor Candidates Are Turned Down? A Single-Center Cohort Study. Cureus. 2020;12(8):e9877. DOI: https://doi.org/10.7759/cureus.9877

Hajj P, Ferlicot S, Massoud W, Awad A, Hammoudi Y, Charpentier B, et al. Prevalence of renal cell carcinoma in patients with autosomal dominant polycystic kidney disease and chronic renal failure. Urology. 2009;74(3):631-4. DOI: https://doi.org/10.1016/j.urology.2009.02.078

Jilg CA, Drendel V, Bacher J, Pisarski P, Neeff H, Drognitz O, et al. Autosomal dominant polycystic kidney disease: prevalence of renal neoplasias in surgical kidney specimens. Nephron Clin Pract. 2013;123(1-2):13-21. DOI: https://doi.org/10.1159/000351049

Gomez G, Althaus A, Gruessner CE, Hirsch MS, Steele GS. Clear cell tubopapillary renal cell carcinoma mimicking polycystic kidney disease: A case report. Urol Case Rep. 2018;16:35-7. DOI: https://doi.org/10.1016/j.eucr.2017.10.003

Issa N, Chedid M, Irazabal MV, Dean PG, Chebib FT. Twenty-Year Survival of Kidney Transplant From a Deceased Donor With Autosomal Dominant Polycystic Kidney Disease. Kidney Int Rep. 2021;6(8):2240-2. DOI: https://doi.org/10.1016/j.ekir.2021.05.030

Ojo AO. Expanded criteria donors: process and outcomes. Semin Dial. 2005;18(6):463-8. DOI: https://doi.org/10.1111/j.1525-139X.2005.00090.x

Bagul A, Olsburgh JD, Calder F. Deceased Polycystic Kidney Donors - Should Be Considered to Expand the Donor Pool: 2480. Transplantation. 2012;94(10S):606-7. DOI: https://doi.org/10.1097/00007890-201211271-01171

Olsburgh JD, Godbole HC, O'Donnell PJ, Koffman GC, Taylor JD, Khan MS. Transplantation of kidneys from deceased adult polycystic donors. Am J Transplant. 2006;6(11):2809-11. DOI: https://doi.org/10.1111/j.1600-6143.2006.01539.x

Baloglu I, Tonbul HZ, Turkmen K, Selcuk NY, Iyisoy MS. Are Kidney Donor Risk Index/Kidney Donor Profile Index Scores Predictor of Future Graft Function? Saudi J Kidney Dis Transpl. 2021;32(4):979-85. DOI: https://doi.org/10.4103/1319-2442.338310